» Articles » PMID: 34858728

Chronic Stress Promotes Breast Carcinoma Metastasis by Accumulating Myeloid-derived Suppressor Cells Through Activating β-adrenergic Signaling

Overview
Journal Oncoimmunology
Date 2021 Dec 3
PMID 34858728
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Numerous studies have found that chronic stress could promote tumor progression and this may be related to inhibtion of immune system. Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of cells with immunosuppressive activity. MDSCs may represent a key link between chronic stress and tumor progression. However, the role of stress-induced MDSCs in breast cancer progression is unclear. The present study showed that pre-exposure of chronic stress could lead to MDSCs elevation and facilitated breast cancer metastasis in tumor-bearing mice. Adoptive transfer of MDSCs could significantly increase lung metastatic foci. In contrast, lung metastasis could be alleviated by depleting endogenous MDSCs with Gr-1 antibody. The concentration of norepinephrine in serum and the expression of tyrosine hydroxylase in bone marrow could be significantly elevated by chronic stress. Moreover, propranolol, an inhibitor of β-adrenergic signaling, could inhibit breast carcinoma metastasis and prevent the expansion of chronic stress-induced MDSCs. Further study revealed that the expressions of IL-6 and JAK/STAT3 signaling pathways were upregulated by chronic stress in mice, and this upregulation could be inhibited by propranolol. Blocking the IL-6 signal or inhibiting the activation of the JAK/STAT3 signaling pathway could reduce tumor growth and metastasis by attenuating the accumulation of MDSCs in vivo. Besides, propranolol inhibited the expression of IL-6 in supernatant of 4T1 cells induced by isoproterenol and reduced the proportion of inducible MDSCs in vitro. Taken together, these data indicated that chronic stress may accumulate MDSCs via activation of β-adrenergic signaling and IL-6/STAT3 pathway, thereby promoting breast carcinoma metastasis.

Citing Articles

HDC downregulation induced by chronic stress promotes ovarian cancer progression via the IL-6/STAT3/S100A9 pathway.

Chen Z, Cao J, Xiao Z, Yang Z, Cheng Y, Duan J Front Pharmacol. 2024; 15:1485885.

PMID: 39720595 PMC: 11666360. DOI: 10.3389/fphar.2024.1485885.


Chronic Stress-Induced and Tumor Derived SP1 Exosomes Polarizing IL-1β Neutrophils to Increase Lung Metastasis of Breast Cancer.

Zhang L, Pan J, Wang M, Yang J, Zhu S, Li L Adv Sci (Weinh). 2024; 12(4):e2310266.

PMID: 39630109 PMC: 11789585. DOI: 10.1002/advs.202310266.


An insight into the role of innate immune cells in breast tumor microenvironment.

Garg S, Rai G, Singh S, Gauba P, Ali J, Dang S Breast Cancer. 2024; 32(1):79-100.

PMID: 39460874 DOI: 10.1007/s12282-024-01645-8.


Dual roles of myeloid-derived suppressor cells in various diseases: a review.

Nepal M, Shah S, Kang K Arch Pharm Res. 2024; 47(7):597-616.

PMID: 39008186 DOI: 10.1007/s12272-024-01504-2.


Allostatic Load/Chronic Stress and Cardiovascular Outcomes in Patients Diagnosed With Breast, Lung, or Colorectal Cancer.

Stabellini N, Cullen J, Bittencourt M, Moore J, Sutton A, Nain P J Am Heart Assoc. 2024; 13(14):e033295.

PMID: 38979791 PMC: 11292743. DOI: 10.1161/JAHA.123.033295.


References
1.
Bunt S, Yang L, Sinha P, Clements V, Leips J, Ostrand-Rosenberg S . Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res. 2007; 67(20):10019-26. PMC: 4402704. DOI: 10.1158/0008-5472.CAN-07-2354. View

2.
Zhang W, Jiang M, Chen J, Zhang R, Ye Y, Liu P . SOCS3 Suppression Promoted the Recruitment of CD11bGr-1F4/80MHCII Early-Stage Myeloid-Derived Suppressor Cells and Accelerated Interleukin-6-Related Tumor Invasion Affecting Myeloid Differentiation in Breast Cancer. Front Immunol. 2018; 9:1699. PMC: 6064721. DOI: 10.3389/fimmu.2018.01699. View

3.
Wu C, Hsieh C, Lin C, Chen W, Hong J, Chen M . Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells. J Mol Med (Berl). 2012; 90(11):1343-55. DOI: 10.1007/s00109-012-0916-x. View

4.
Gabrilovich D, Nagaraj S . Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009; 9(3):162-74. PMC: 2828349. DOI: 10.1038/nri2506. View

5.
Phadke S, Clamon G . Beta blockade as adjunctive breast cancer therapy: A review. Crit Rev Oncol Hematol. 2019; 138:173-177. DOI: 10.1016/j.critrevonc.2019.04.006. View